Author

Ana Fernandez-Montes

Observed names: Ana Fernandez Fernandez Montes, Ana Fernández Montes, Ana Fernández-Montes

Institution: Complejo Hospitalario de Ourense

Observed institution: Complejo Hospitalario de Ourense

ORCID: 0000-0003-4630-5830

Observed ORCID: 0000-0003-4630-5830

OpenAlex ID: A5121104734

Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer

2025 · Florian Castet, Carles Fabregat-Franco, et al. · Journal of Hepatology · 6

Long-term responders to trifluridine/tipiracil plus bevacizumab in previously treated metastatic colorectal cancer: Results from the BeTAS real-world study.

2026 · Nieves Martinez Lago, Margarita Reboredo Lopez, et al. · Journal of Clinical Oncology · 1

Epidemiological characterization of biliary tract cancer patients from the Spanish RETUD Registry.

2026 · Teresa Macarulla, Florian Castet, et al. · Journal of Clinical Oncology · 1

Interventional strategies to address burnout in young medical oncologists: results from the Resilience-Spanish Society of Medical Oncology (SEOM) Study and a university hospital experience in Spain

2025 · Vilma Pacheco-Barcia, Berta Obispo, et al. · Clinical & Translational Oncology · 1

Phase III CR-SEQUENCE trial of FOLFOX+panitumumab followed by FOLFIRI+bevacizumab (SEQ1) versus FOLFOX + bevacizumab followed by FOLFIRI + panitumumab (SEQ2) in previously untreated RAS wild-type, left-sided, unresectable metastatic colorectal cancer.

2026 · Ramon Salazar, Maria Auxiliadora Gomez, et al. · Journal of Clinical Oncology

Role of microbiota in response to treatment in anal squamous cell carcinoma.

2026 · Jaime Feliú, Andrea Garcia-Leal, et al. · Journal of Clinical Oncology

FRUQUITAS trial: Study design of an ENGIC intergroup randomized phase III of trifluridine/tipiracil +/- fruquintinib in pre-treated metastatic gastro-oesophageal adenocarcinoma

2026 · David Tougeron, Fernando Rivera, et al. · Digestive and Liver Disease

Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain

2026 · Paula Jimenez-Fonseca, Marc Diez Garcia, et al. · Clinical & Translational Oncology

SEOM–GEMCAD–TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)

2026 · Ana Fernández-Montes, Julia Alcaide, et al. · Clinical & Translational Oncology

Comparative prognostic performance of the REBECCA score and the Tabernero classification in refractory metastatic colorectal cancer treated with regorafenib: a multicenter real-world study

2026 · Nieves Martínez-Lago, Beatriz Carnero López, et al. · BMC Cancer

SEOM–GEMCAD–TTD clinical guidelines for anal cancer (2025)

2026 · Mónica Guillot Morales, Ana Fernández Montes, et al. · Clinical & Translational Oncology

Isocitrate dehydrogenase 1 mutations in biliary tract cancer patients in Spanish RETUD registry.

2026 · Andrés J. Muñoz Martín, Florian Castet, et al. · Journal of Clinical Oncology

Liver metastases: comprehensive medical management, conversion to resectability, coordination with surgery

2026 · Soledad Cameselle-García, Maria Lourdes García Jiménez, et al. · Revisiones en cáncer

Works count: 13

Citation count: 9

H-index: 1

I10-index: